Events & Training

Each year the FSANZ holds a Scientific Meeting attracting experts in reproductive health from around the world to present research and discuss new technologies and treatments.
In addition, the FSANZ will continue to develop training programs to assist its members with their professional development, an example of this would be START (Start-up Training in Reproductive Technology).

Events
Training

Events

Fertility Society of Australia and New Zealand Annual Conference

The Organising Committee is putting together an excellent program for the Fertility Society of Australia and New Zealand Annual Conference 2024 (FSANZ 2024).

The conference will be held at the Crown Convention Centre, Perth, Western Australia from 14 - 17 September 2024.

Further information regarding the conference will be available shortly.

training and events
“The Fertility Society of Australia of Australia and New Zealand annual 2024 conference takes place in Perth. Save the date.”

Crown Convention Centre, Perth, Western Australia

14 - 17 September 2024
Conference website coming soon

Events

ABSTRACTS FSANZ ANNUAL CONFERENCE 2023

A PDF copy of FSA 2023 abstracts is available for download.

Training

Start-up Training in Assisted Reproductive Technology

Dates

8 & 9 March 2025

Cost

Further information will be available shortly

Venue

Novotel Sydney Brighton Beach
2 Princess Street, Brighton Le Sands NSW

HOW TO REGISTER

Registration will open November 2024

Feedback and comments from previous attendees

A great overview of what ART services are all about and I think that the course is such a valuable teaching tool for new members coming into the industry. There is really no other place to go for information apart from websites and on the job learning. I think that a course of this nature is crucial for the ongoing learning and education of new staff.
The START program was very insightful and helpful in terms of overall background knowledge and the implications/applications of IVF treatment.
I have been in the IVF / fertility environment for 6 months. I feel this was great timing to further my knowledge and support the my understanding of how fertility works and how I can support the clinical team. I would strongly recommend this course to anyone new to fertility.
I think the program offers relevant information from all of the aspects of reproductive technology for anyone new to the industry. Regardless of which area you work in, it allows for excellent overall understanding of the technology, and the role it has in the community.
It was fantastic, very useful for the beginner in the IVF field.
Exceptionally useful program and organisation- thank you!
Thanks for a fab weekend – I’ve been in IVF for six months and the conference was perfect for my learning needs.
Excellent work I loved it and would be interested in knowing of any more courses that become available.

HREC Requirements

Requirement for Human Research Ethics Committee Approval

In their strive to improve clinical and psycho-social outcomes for couples who have IVF, many FSANZ members conduct research as part of their clinical role. The results of these endeavours are often presented at our society’s Annual Scientific Meeting. The importance of research to provide evidence for best practice cannot be emphasized enough. However, equally important is that the research is conducted according to the ethical principles set out in the NHMRC National Statement on Ethical Conduct in Human Research 2007.

In line with other societies and to comply with the NHMRC statement the FSANZ Board has decided that from 2010, abstracts submitted for presentation at the Annual Scientific Meeting which involve human subjects require Human Research Ethics Committee (HREC) approval. This requirement is implemented to maintain high standards of presentation, to protect the interests of patients/subjects, and to ensure that studies presented at the meeting have the potential to be submitted and accepted for publication. Studies that do not have HREC approval cannot be published in scientific journals and should not be presented at scientific meetings.

All HRECs operate under the guidelines of the NHMRC National Statement on Ethical Conduct in Human Research 2007. This document addresses the question of what constitutes ‘human research’.

Human Research is conducted with or about people or their data or tissue. Human participation in research is, therefore, to be understood broadly to involve human beings through:

  • taking part in surveys, interviews or focus groups
  • undergoing psychological, physiological or medical testing or treatment
  • being observed by researchers
    researchers having access to their personal documents or other materials
  • the collection and use of their body organs, tissues or fluids ( eg skin, blood, urine, saliva, hair, bones, tumour and other biopsy specimens)
  • access to their information (in individually identifiable, re-identifiable or non-identifiable form) as part of an existing published or unpublished source or database” NHMRC National Statement on Ethical Conduct in Human Research 2007, p.8

This is the sort of information that is usually required in an HREC application:

  • Aims/objectives of the study
  • Hypothesis
  • Study design and methodology
  • Study population (sample size, inclusion/exclusion criteria)
  • Data analysis
  • Investigator obligations (storage of data, confidentiality, adverse event reporting, handling of adverse events)
  • List of references of other researchers in the field
  • Information for participants and participant’s consent form
  • Mechanism for reporting on progress of the study

Following are some hypothetical examples of abstracts with reference to whether or not they would require HREC approval.

  • A clinic has introduced a new intake program for patients commencing IVF. A nurse wishes to present the content and format of this program. This paper would not require HREC approval providing it is descriptive of the program, and not inclusive of patient surveys.
  • An embryologist wishes to present a retrospective analysis of embryo quality with the use of a new culture medium. The information will be collected from patients’ medical records but the data presented will be non-identifiable. This study would require HREC approval because even though the data is non-identifiable it involves the researcher accessing patients’ medical records.
  • A medical student wishes to present a prospective study of the relationship between IVF outcomes and stress levels (assessed by a standardised measure) prior to commencing treatment. This would require HREC approval as it both requires psychological testing of patients and accessing information from their medical records.
  • A counsellor wishes to present a literature review of evidence regarding mother/infant attachment following embryo donation. As this abstract involves only a literature review and no access to patient data, it would not require HREC approval.

The FSANZ Board is confident that the requirement for HREC approval for human research presented at the Annual Scientific Meeting will enhance the quality of the important research conducted by FSANZ members.